Persones / Equip Humà

Jordi Antón López

Buscador de publicacions

Publicacions

  • Fernández-Cooke E, Tascón AB, Anton-Lopez J, Grasa Lozano CD, Sánchez-Manubens J and Calvo C.

    Previous or coincident infections with suspected Kawasaki disease. Should we change our approach?

    anales de pediatria . 90(4): 213-218.

    [doi:10.1016/j.anpede.2018.06.011]

  • Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, Bovis F, De Inocencio J, Demirkaya E, Flato B, Foell D, Garay SM, Lazar C, Lovell DJ, Montobbio C, Miettunen P, Mihaylova D, Nielsen S, Orban I, Rumba-Rozenfelde I, Magalhães CS, Shafaie N, Susic G, Trachana M, Wulffraat N, Pistorio A, Martini A, Ruperto N, Ravelli A and Paediatric Rheumatology International Trials Organisation.

    Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study.

    LANCET CHILD & ADOLESCENT HEALTH . 3(4): 255-263. Nº de cites: 125

    [doi:10.1016/S2352-4642(19)30027-6]

  • Rabionet-Janssen R, Remesal A, Mensa-Vilaró A, Murías S, Alcobendas R, González-Roca E, Ruiz-Ortiz E, Anton-Lopez J, Iglesias-Jimenez E, Modesto C, Comas D, Puig A, Drechsel O, Ossowski S, Yagüe-Ribes J, Merino R, Estivill X and Arostegui-Gorospe JI.

    Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis

    SCIENTIFIC REPORTS . 9: 4579-4579. Nº de cites: 20

    [doi:10.1038/s41598-019-40874-2]

  • Sánchez-Manubens J, Iglesias-Jimenez E and Anton-Lopez J.

    Canakinumab for the treatment of hyperimmunoglobulin D syndrome

    EXPERT REVIEW OF CLINICAL IMMUNOLOGY . 15(3): 215-220. Nº de cites: 7

    [doi:10.1080/1744666X.2019.1571410]

  • Patterson K, Iglesias-Jimenez E, Nasrallah M, González V, Suñol M, Anton-Lopez J, Saiz A, Lancaster E and Armangue-Salvador T.

    Anti-MOG encephalitis mimicking small vessel CNS vasculitis

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 6(2): 538. Nº de cites: 52

    [doi:10.1212/NXI.0000000000000538]

  • Foeldvari, I, Klotsche, J, Torok, KS, Kasapcopur, O, Adrovic, A, Stanevicha, V, Terreri, MT, Alexeeva, E, Katsicas, M, Cimaz, R, Kostik, M, Lehman, T, Sifuentes-Giraldo, WA, Smith, V, Sztajnbok, F, Avcin, T, Santos, MJ, Moll, M, Nemcova, D, Battagliotti, C, Eleftheriou, D, Janarthanan, M, Kallinich, T, Anton-Lopez J, Minden, K, Nielsen, S, Uziel, Y and Helmus, N.

    Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort

    Journal of Scleroderma and Related Disorders . 4(1): 49-61. Nº de cites: 19

    [doi:10.1177/2397198318790494]

  • Navallas M, Inarejos E, Iglesias-Jimenez E, Rebollo M, Anton-Lopez J and Navarro OM.

    Connective Tissue Disorders in Childhood: Are They All the Same?

    RADIOGRAPHICS . 39(1): 229-250. Nº de cites: 8

    [doi:10.1148/rg.2019180078]

  • Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E, Panaviene V, Bader-Meunier B, Anton-Lopez J, Nielsen S, De Benedetti F, Kamphuis S, Stanevica V, Tracahana M, Ailioaie LM, Tsitsami E, Klein A, Minden K, Foeldvari I, Haas JP, Klotsche J, Horne AC, Consolaro A, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and th.

    Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.

    ARTHRITIS RESEARCH & THERAPY . 20(1): 285-285. Nº de cites: 69

    [doi:10.1186/s13075-018-1780-z]

  • Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton-Lopez J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, Foster HE, Foell D, Radominski SC, Ramanan AV, Trauzeddel R, Unsal E, Levy J, Vritzali E, Martini A and Lovell DJ.

    Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.

    ANNALS OF THE RHEUMATIC DISEASES . 77(12): 1710-1719. Nº de cites: 69

    [doi:10.1136/annrheumdis-2018-213150]

  • Marrani E, Foeldvari I, Anton-Lopez J, Cimaz R and Simonini G.

    Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach

    SEMINARS IN ARTHRITIS AND RHEUMATISM . 48(3): 495-503. Nº de cites: 18

    [doi:10.1016/j.semarthrit.2018.03.003]